Moderna: Q4 Earnings Snapshot

SelfRugger · 2026-03-16T17:26:17+00:00

Moderna reported a fourth-quarter loss of $826 million, amounting to $2.11 per share, which exceeded analyst predictions. The company generated $678 million in revenue, also surpassing forecasts. For the year, losses totaled $2.82 billion.

SelfRugger

2026-03-16 17:26:17

Abstract generation in progress

Moderna: Q4 Earnings Snapshot

Associated Press Finance

Fri, February 13, 2026 at 9:15 PM GMT+9 1 min read

In this article:

MRNA

-0.99%

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Friday reported a loss of $826 million in its fourth quarter.

The Cambridge, Massachusetts-based company said it had a loss of $2.11 per share.

The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $2.60 per share.

The biotechnology company posted revenue of $678 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $659.5 million.

For the year, the company reported a loss of $2.82 billion, or $7.26 per share. Revenue was reported as $1.94 billion.

This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on MRNA at

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.